The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic has posed a
huge threat to global health because of its rapid spread and various mutant variants. Critical …

Favipiravir, a broad-spectrum RNA-dependent RNA polymerase inhibitor, inhibits the
replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at …

Background. Patients on kidney replacement therapy comprise a vulnerable population and
may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently …

Rationale & Objective Underlying kidney disease is an emerging risk factor for more severe
coronavirus disease 2019 (COVID-19) illness. We examined the clinical courses of critically …

Abstract Background Coronavirus disease 2019 (COVID-19) has exposed haemodialysis
(HD) patients and kidney transplant (KT) recipients to an unprecedented life-threatening …

Many studies reported a higher risk of COVID-19 disease among patients on dialysis or with
kidney transplantation, and the poor outcome of COVID-19 in these patients. Patients in …

Importance There is a need for studies to evaluate the risk factors for COVID-19 and
mortality among the entire Medicare long-term dialysis population using Medicare claims …

Abstract Background Remdesivir (RDV) is US FDA approved for coronavirus disease 2019
(COVID-19) but not recommended in severe renal impairment (SRI, Creatinine clearance< …

Background Acute kidney injury (AKI) is common in coronavirus disease-2019 (COVID-19)
and the severity of AKI is linked to adverse outcomes. In this study, we investigated the …

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections in late 2019, the world has faced a major healthcare challenge. There remains …